Moderna Shares Tank After FDA Delays COVID Vaccine For 12-17 Year Olds

Source: FOX Business

“The U.S. Food and Drug Administration (FDA) on Friday (October 29, 2012) notified Moderna that the agency would require additional time to review and evaluate possible risks associated with the vaccine – particularly, a possible risk of myocarditis after vaccination.”

A small victory, but an important one, in the continued “assault” of the damage and impact of the plandemic (which with a little research can be seen to be much larger than the mainstream narrative, including this article, portray), by well-oiled monied and power-grabbing interests!

Focusing on a new reality of love and well-being for all of us!

Da Amber San